Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Engage Grants Program

Dalhousie University

$23,867.00

Development of a prototype device that can be used to rapidly determine the effectiveness of orange blueblocker protective glasses/shields against ocular light induced hazards.

EF 2011-12

Résumé
We propose to collaborate with BlueLight analytics inc., a Halifax based manufacturer of dental devices, to develop a portable prototype device that can be used to rapidly determine the effectiveness of orange blueblocker protective lenses. The greatest ocular hazard to blue-light occurs at approximately 440 nm (which is close to the peak wavelength of many dental curing lights). Blue light is transmitted through the ocular media and absorbed by the retina; at chronic low levels of exposure, the blue light amplifies retinal aging and degeneration by causing photochemical injury to the retinal-pigmented epithelium and choroid. Clinical manifestations of retinal damage include acute photoretinitis or, in severe cases, premature age-related macular degeneration. BlueLight currently manufactures a device to measure the effectiveness of light delivery to dental fillings. The device, MARC TM, is based on a fiberoptic spectrometer and comes with proprietary software. MARC is used by dental manufacturers to assess and develop new polymeric resins and is also being used to teach proper resin curing techniques. BlueLight recommends that orange blueblocker protective lenses be worn during light curing. In this project, we will work with BlueLight to develop a prototype device based on MARC that can rapidly analyse and compare the effectiveness of orange blueblocking glasses. BlueLight believes that this type of new device would have significant uses in the medical and dental fields. The device could be used synergistically with MARC and that there is a significant new market opportunity for Bluelight in this area. BlueLight is very interested to determine if such a device is feasible and can be developed for both research and commercial use.
Programme
Engage Grants Program
Bénéficiaire
Emplacement
Nova Scotia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
417924-2011
Name nom
Labrie, Daniel
Department département
Physics and Atmospheric Science
Organization id
79
Institution établissement
Dalhousie University
Province en
Nova Scotia
Province fr
Nouvelle-Écosse
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2011
Competition year année de concours
2011
Award amount
23867
Program id
EGP
Program nane en
Engage Grants Program
Program name fr
Programme de subventions d'engagement partenariat
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1551
Committee name en
Atlantic Internal Decision Committee
Committee name fr
Comité de décision interne pour l'Atlantique
Area of application code
515
Area of application group en
Manufacturing processes and products
Area of application group fr
Procédés et produits industriels
Area of application en
Instrumentation technology
Area of application fr
Technologie de l'instrumentation
Research subject code
3110
Research subject group en
Physics
Research subject group fr
Physique
Research subject en
Optics (see also photon devices2505)
Research subject fr
Optique (voir aussi dispositifs photoniques, 2505)
Partie
1
Nb partie
1
Application title
Development of a prototype device that can be used to rapidly determine the effectiveness of orange blueblocker protective glasses/shields against ocular light induced hazards.
Keyword
NSERC
Application summary
We propose to collaborate with BlueLight analytics inc., a Halifax based manufacturer of dental devices, to develop a portable prototype device that can be used to rapidly determine the effectiveness of orange blueblocker protective lenses. The greatest ocular hazard to blue-light occurs at approximately 440 nm (which is close to the peak wavelength of many dental curing lights). Blue light is transmitted through the ocular media and absorbed by the retina; at chronic low levels of exposure, the blue light amplifies retinal aging and degeneration by causing photochemical injury to the retinal-pigmented epithelium and choroid. Clinical manifestations of retinal damage include acute photoretinitis or, in severe cases, premature age-related macular degeneration. BlueLight currently manufactures a device to measure the effectiveness of light delivery to dental fillings. The device, MARC TM, is based on a fiberoptic spectrometer and comes with proprietary software. MARC is used by dental manufacturers to assess and develop new polymeric resins and is also being used to teach proper resin curing techniques. BlueLight recommends that orange blueblocker protective lenses be worn during light curing. In this project, we will work with BlueLight to develop a prototype device based on MARC that can rapidly analyse and compare the effectiveness of orange blueblocking glasses. BlueLight believes that this type of new device would have significant uses in the medical and dental fields. The device could be used synergistically with MARC and that there is a significant new market opportunity for Bluelight in this area. BlueLight is very interested to determine if such a device is feasible and can be developed for both research and commercial use.